Related references
Note: Only part of the references are listed.FGF21 (Fibroblast Growth Factor 21) Defines a Potential Cardiohepatic Signaling Circuit in End-Stage Heart Failure
Salah Sommakia et al.
CIRCULATION-HEART FAILURE (2022)
Elevated Serum Fibroblast Growth Factor 21 Is Relevant to Heart Failure Patients with Reduced Ejection Fraction
Liuzhang Fan et al.
COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE (2022)
DPP-4 inhibitor induces FGF21 expression via sirtuin 1 signaling and improves myocardial energy metabolism
Nozomi Furukawa et al.
HEART AND VESSELS (2021)
Fibroblast Growth Factor 21 Correlates with the Prognosis of Dilated Cardiomyopathy
Lingyun Gu et al.
CARDIOLOGY (2021)
Constitutive and Regulated Shedding of Soluble FGF Receptors Releases Biologically Active Inhibitors of FGF-2
Anne Hanneken et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Age dependent associations of risk factors with heart failure: pooled population based cohort study
Jasper Tromp et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
The Comprehensive Machine Learning Analytics for Heart Failure
Chao-Yu Guo et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Theresa A. McDonagh et al.
EUROPEAN HEART JOURNAL (2021)
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
Stefan D. Anker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Diagnostic Performance of Serum Biomarkers Fibroblast Growth Factor 21, Galectin-3 and Copeptin for Heart Failure with Preserved Ejection Fraction in a Sample of Patients with Type 2 Diabetes Mellitus
Raluca D. Ianos et al.
DIAGNOSTICS (2021)
Could a Multi-Marker and Machine Learning Approach Help Stratify Patients with Heart Failure?
Manuela Lotierzo et al.
MEDICINA-LITHUANIA (2021)
High-Level Serum Fibroblast Growth Factor 21 Concentration Is Closely Associated With an Increased Risk of Cardiovascular Diseases: A Systematic Review and Meta-Analysis
Yucong Zhang et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
SGLT2 inhibitors decrease cardiovascular death and heart failure hospitalizations in patients with heart failure: A systematic review and meta-analysis
Rhanderson Cardoso et al.
ECLINICALMEDICINE (2021)
Relationship of fibroblast growth factor 21 levels with inflammation, lipoproteins and non-alcoholic fatty liver disease
Bradley Tucker et al.
ATHEROSCLEROSIS (2020)
Evaluation and management of heart failure with preserved ejection fraction
Barry A. Borlaug
NATURE REVIEWS CARDIOLOGY (2020)
PGC-1α, Inflammation, and Oxidative Stress: An Integrative View in Metabolism
Sergio Rius-Perez et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Fibroblast growth factor-21 potentiates glucose transport in skeletal muscle fibers
G. Rosales-Soto et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2020)
The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic
Leiluo Geng et al.
NATURE REVIEWS ENDOCRINOLOGY (2020)
FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases
Erik J. Tillman et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Reappraisal of Inflammatory Biomarkers in Heart Failure
Thanat Chaikijurajai et al.
CURRENT HEART FAILURE REPORTS (2020)
Key inflammatory mechanisms underlying heart failure
C. Riehle et al.
HERZ (2019)
Exercise Alleviates Obesity-Induced Metabolic Dysfunction via Enhancing FGF21 Sensitivity in Adipose Tissues
Leiluo Geng et al.
CELL REPORTS (2019)
Relationship of fibroblast growth factor 21 with subclinical atherosclerosis and cardiovascular events: Multi-Ethnic Study of Atherosclerosis
Kwok Leung Ong et al.
ATHEROSCLEROSIS (2019)
Going Back to the Biology of FGF21: New Insights
Jo E. Lewis et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2019)
Fibroblast growth factor 21 in patients with cardiac cachexia: a possible role of chronic inflammation
Maria Refsgaard Holm et al.
ESC HEART FAILURE (2019)
Fibroblast growth factor 21 in non-alcoholic fatty liver disease
Bradley Tucker et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Heart Failure and Liver Disease Cardiohepatic Interactions
Andrew Xanthopoulos et al.
JACC-HEART FAILURE (2019)
SGLT2 inhibition reprograms systemic metabolism via FGF21-dependent and -independent mechanisms
Soravis Osataphan et al.
JCI INSIGHT (2019)
The relationship of circulating fibroblast growth factor 21 levels with incident atrial fibrillation: The Multi-Ethnic Study of Atherosclerosis
Tsz Him Hui et al.
ATHEROSCLEROSIS (2018)
Serum FGF21 Is Associated with Future Cardiovascular Events in Patients with Coronary Artery Disease
Yun Shen et al.
CARDIOLOGY (2018)
FGF21 Prevents Angiotensin II-Induced Hypertension and Vascular Dysfunction by Activation of ACE2/Angiotensin-(1-7) Axis in Mice
Xuebo Pan et al.
CELL METABOLISM (2018)
Do DPP-4 Inhibitors Cause Heart Failure Events by Promoting Adrenergically Mediated Cardiotoxicity?: Clues From Laboratory Models and Clinical Trials
Milton Packer
CIRCULATION RESEARCH (2018)
Low Plasma Levels of Fibroblast Growth Factor-21 in Patients with Peripheral Artery Disease
Yoshichika Miyazaki et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2018)
Fibroblast growth factor 21 in cardio-metabolic disorders: a systematic review and meta-analysis
Ishan Lakhani et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2018)
Risk Prediction Models for Incident Heart Failure: A Systematic Review of Methodology and Model Performance
Berhe W. Sahle et al.
JOURNAL OF CARDIAC FAILURE (2017)
The Potential Role of Fibroblast Growth Factor 21 in Lipid Metabolism and Hypertension
Zhe Huang et al.
CURRENT HYPERTENSION REPORTS (2017)
Understanding the Physiology of FGF21
Ffolliott Martin Fisher et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 78 (2016)
Current and projected burden of heart failure in the Australian adult population: a substantive but still ill-defined major health issue
Yih-Kai Chan et al.
BMC HEALTH SERVICES RESEARCH (2016)
A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects
Saswata Talukdar et al.
CELL METABOLISM (2016)
Lipid Use and Misuse by the Heart
P. Christian Schulze et al.
CIRCULATION RESEARCH (2016)
Association Between Serum Fibroblast Growth Factor 21 and Mortality Among Patients With Coronary Artery Disease
Qing Li et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Circulating Fibroblast Growth Factor 21 is Associated with Diastolic Dysfunction in Heart Failure Patients with Preserved Ejection Fraction
Ruey-Hsing Chou et al.
SCIENTIFIC REPORTS (2016)
Heart Failure: Diagnosis, Management and Utilization
Arati A. Inamdar et al.
JOURNAL OF CLINICAL MEDICINE (2016)
Pathophysiology of Heart Failure
Edit Tanai et al.
COMPREHENSIVE PHYSIOLOGY (2016)
Mortality in heart failure patients
Ibadete Bytyci et al.
ANATOLIAN JOURNAL OF CARDIOLOGY (2015)
FGF21 attenuates pathological myocardial remodeling following myocardial infarction through the adiponectin-dependent mechanism
Yusuke Joki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes
Yang Xiao et al.
CARDIOVASCULAR DIABETOLOGY (2015)
Recent Developments in Heart Failure
Sujith Dassanayaka et al.
CIRCULATION RESEARCH (2015)
Population Risk Prediction Models for Incident Heart Failure A Systematic Review
Justin B. Echouffo-Tcheugui et al.
CIRCULATION-HEART FAILURE (2015)
Serum fibroblast growth factor 21 levels are increased in atrial fibrillation patients
Xinyuan Han et al.
CYTOKINE (2015)
Fibroblast growth factor 21 protects the heart from apoptosis in a diabetic mouse model via extracellular signal-regulated kinase 1/2-dependent signalling pathway
Chi Zhang et al.
DIABETOLOGIA (2015)
Association between Serum Fibroblast Growth Factor 21 and Coronary Artery Disease in Patients with Type 2 Diabetes
Won Jin Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2015)
Tissue-specific actions of the metabolic hormones FGF15/19 and FGF21
Bryn M. Owen et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2015)
The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting
Emmert Roberts et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting
Emmert Roberts et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
FGF21 and cardiac physiopathology
Anna Planavila et al.
FRONTIERS IN ENDOCRINOLOGY (2015)
Fibroblast growth factor 21 protects the heart from oxidative stress
Anna Planavila et al.
CARDIOVASCULAR RESEARCH (2015)
Circulating levels of fibroblast growth factor-21 increase with age independently of body composition indices among healthy individuals
Lynae J. Hanks et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY (2015)
FGF21 Acts Centrally to Induce Sympathetic Nerve Activity, Energy Expenditure, and Weight Loss
Bryn M. Owen et al.
CELL METABOLISM (2014)
Serum FGF21 concentration is associated with hypertriglyceridaemia, hyperinsulinaemia and pericardial fat accumulation, independently of obesity, but not with current coronary artery status
Yenna Lee et al.
CLINICAL ENDOCRINOLOGY (2014)
Circulating FGF21 Is Liver Derived and Enhances Glucose Uptake During Refeeding and Overfeeding
Kathleen R. Markan et al.
DIABETES (2014)
The annual global economic burden of heart failure
Christopher Cook et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
FGF21 is an endocrine signal of protein restriction
Thomas Laeger et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
The pathophysiology of heart failure with preserved ejection fraction
Barry A. Borlaug
NATURE REVIEWS CARDIOLOGY (2014)
Novel Insights into the Cardio-Protective Effects of FGF21 in Lean and Obese Rat Hearts
Vanlata Patel et al.
PLOS ONE (2014)
Heart failure: preventing disease and death worldwide
Piotr Ponikowski et al.
ESC HEART FAILURE (2014)
Serum Fibroblast Growth Factor-21 Levels Are Associated With Carotid Atherosclerosis Independent of Established Cardiovascular Risk Factors
Wing Sun Chow et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Biomarkers and diagnostics in heart failure
Hanna K. Gaggin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Adiponectin Mediates the Metabolic Effects of FGF21 on Glucose Homeostasis and Insulin Sensitivity in Mice
Zhuofeng Lin et al.
CELL METABOLISM (2013)
An FGF21-Adiponectin-Ceramide Axis Controls Energy Expenditure and Insulin Action in Mice
William L. Holland et al.
CELL METABOLISM (2013)
The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes
Gregory Gaich et al.
CELL METABOLISM (2013)
High Glucose Represses β-Klotho Expression and Impairs Fibroblast Growth Factor 21 Action in Mouse Pancreatic Islets Involvement of Peroxisome Proliferator-Activated Receptor γ Signaling
Wing Yan So et al.
DIABETES (2013)
Mild Cold Exposure Modulates Fibroblast Growth Factor 21 (FGF21) Diurnal Rhythm in Humans: Relationship between FGF21 Levels, Lipolysis, and Cold-Induced Thermogenesis
Paul Lee et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Fibroblast growth factor 21 is a sensitive biomarker of mitochondrial disease
Ryan L. Davis et al.
NEUROLOGY (2013)
Acute Exercise Induces FGF21 Expression in Mice and in Healthy Humans
Kook Hwan Kim et al.
PLOS ONE (2013)
Endocrine Protection of Ischemic Myocardium by FGF21 from the Liver and Adipose Tissue
Shu Q. Liu et al.
SCIENTIFIC REPORTS (2013)
The pathophysiology of heart failure
Clinton D. Kemp et al.
CARDIOVASCULAR PATHOLOGY (2012)
Endocrine fibroblast growth factors 15/19 and 21: from feast to famine
Matthew J. Potthoff et al.
GENES & DEVELOPMENT (2012)
FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis
Ffolliott M. Fisher et al.
GENES & DEVELOPMENT (2012)
The paradox of low BNP levels in obesity
Aldo Clerico et al.
HEART FAILURE REVIEWS (2012)
Rationale-Based Engineering of a Potent Long-Acting FGF21 Analog for the Treatment of Type 2 Diabetes
Randy Hecht et al.
PLOS ONE (2012)
Oxidative stress and heart failure
Hiroyuki Tsutsui et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Natriuretic Peptide Testing in Heart Failure
Han-Na Kim et al.
CIRCULATION (2011)
Fibroblast Growth Factor 21 (FGF21) in Human Cerebrospinal Fluid Relationship With Plasma FGF21 and Body Adiposity
Bee K. Tan et al.
DIABETES (2011)
Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity
Fredirick L. Mashili et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2011)
Thermogenic Activation Induces FGF21 Expression and Release in Brown Adipose Tissue
Elayne Hondares et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The cardiokine story unfolds: ischemic stress-induced protein secretion in the heart
Shirin Doroudgar et al.
TRENDS IN MOLECULAR MEDICINE (2011)
Fibroblast Growth Factor 21 Action in the Brain Increases Energy Expenditure and Insulin Sensitivity in Obese Rats
David A. Sarruf et al.
DIABETES (2010)
Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State
Ffolliott M. Fisher et al.
DIABETES (2010)
Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease
Jody Dushay et al.
GASTROENTEROLOGY (2010)
Research Resource: Comprehensive Expression Atlas of the Fibroblast Growth Factor System in Adult Mouse
Klementina Fon Tacer et al.
MOLECULAR ENDOCRINOLOGY (2010)
Mitochondrial oxidative stress and dysfunction in myocardial remodelling
Hiroyuki Tsutsui et al.
CARDIOVASCULAR RESEARCH (2009)
Circulating Biomarkers for the Diagnosis and Prognosis of Heart Failure
D. Tousoulis et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Fibroblast Growth Factor 21 Reduces the Severity of Cerulein-Induced Pancreatitis in Mice
Charis L. Johnson et al.
GASTROENTEROLOGY (2009)
Circulating Fibroblast Growth Factor 21 Is Induced by Peroxisome Proliferator-Activated Receptor Agonists But Not Ketosis in Man
Constantinos Christodoulides et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
The FGF family: biology, pathophysiology and therapy
Andrew Beenken et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
FGF21 induces PGC-1α and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response
Matthew J. Potthoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans
Xinmei Zhang et al.
DIABETES (2008)
Circulating FGF-21 levels in normal subjects and in newly diagnose patients with type 2 diabetes Mellitus
W. -W. Chen et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2008)
Tissue-specific expression of βKlotho and fibroblast growth factor (FGF) receptor Isoforms determines metabolic activity of FGF19 and FGF21
Hiroshi Kurosu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Hepatic fibroblast growth factor 21 is regulated by PPARα and is a key mediator of hepatic lipid metabolism in ketotic states
Michael K. Badman et al.
CELL METABOLISM (2007)
Endocrine regulation of the fasting response by PPARα-mediated induction of fibroblast growth factor 21
Takeshi Inagaki et al.
CELL METABOLISM (2007)
CVD risk factors and ethnicity - A homogeneous relationship?
Nita G. Forouhi et al.
ATHEROSCLEROSIS SUPPLEMENTS (2006)
Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways
Wolf Wente et al.
DIABETES (2006)
FGF-21 as a novel metabolic regulator
A Kharitonenkov et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Lipotoxicity: when tissues overeat
JE Schaffer
CURRENT OPINION IN LIPIDOLOGY (2003)
The prognosis of heart failure in the general population - The Rotterdam Study
A Mosterd et al.
EUROPEAN HEART JOURNAL (2001)
Share Paper
